Evidence map›Paper›PMID 18483468›Full record

ReviewMolecules and cells2008

Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.

Melissa D Shelton, John J Mieyal

Abstract readReview
In one paragraph

Review in Molecules and cells, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. The role of thiols in antioxidant systems.Free radical biology & medicine · 2019
    Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Melissa D SheltonDepartment of Pharmacology, School of Medicine, Case Western Reserve University, and Louis Stokes Cleveland Veterans Affairs Medical Research Center, Cleveland, Ohio 44106-4965, USA.
John J Mieyal
Case Comprehensive Cancer CenterLouis Stokes Cleveland VA Medical Center · US

Funding

SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXINP01AG015885 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI HOPPEL, CHARLES LESLIE · 1998 to 2008
$8.1M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
Sulfhydryl Status in Aging Heart: Role of GlutaredoxinR01AG024413 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI MIEYAL, JOHN J · 2004 to 2006
$683k
NEI NIH HHS 5 T32 EY07157NEI NIH HHS T32 EY007157NIA NIH HHS 1 P01 AG 15885NIA NIH HHS 1 R01 AG024413NIA NIH HHS P01 AG015885NIA NIH HHS R01 AG024413
6 · The paper itself

Abstract

S-glutathionylation is a reversible post-translational modification that continues to gain eminence as a redox regulatory mechanism of protein activity and associated cellular functions. Many diverse cellular proteins such as transcription factors, adhesion molecules, enzymes, and cytokines are reported to undergo glutathionylation, although the functional impact has been less well characterized. De-glutathionylation is catalyzed specifically and efficiently by glutaredoxin (GRx, aka thioltransferase), and facile reversibility is critical in determining the physiological relevance of glutathionylation as a means of protein regulation. Thus, studies with cohesive themes addressing both the glutathionylation of proteins and the corresponding impact of GRx are especially useful in advancing understanding. Reactive oxygen species (ROS) and redox regulation are well accepted as playing a role in inflammatory processes, such as leukostasis and the destruction of foreign particles by macrophages. We discuss in this review the current implications of GRx and/or glutathionylation in the inflammatory response and in diseases associated with chronic inflammation, namely diabetes, atherosclerosis, inflammatory lung disease, cancer, and Alzheimer's disease, and in viral infections.

Indexed as

Protein Processing, Post-TranslationalCytokinesGlutaredoxinsGlutathioneHumansInflammationInflammation MediatorsMacrophagesMonocytesReactive Oxygen SpeciesVirus DiseasesCytokinesGlutaredoxinsGlutathioneInflammation MediatorsReactive Oxygen Species

Identifiers

PMID18483468
PMCPMC3367451
OpenAlexW83659299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.